Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

GW786034, VOTRIENT,Pazopanib Hydrochloride|

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 14 USDMF, 1 JDMF, 8 EU WC, 6 KDMF, 9 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

96 Drugs in Development

96 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

96 FDF Dossiers, 8 FDA Orange Book, 36 Europe, 3 Canada, 24 Australia, 7 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Controlled & Modified Release, 17 Solubilizers, 16 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 10 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Parenteral, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 API Stability Enhancers, 4 Taste Masking

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 10 Annual Reports

MARKET PLACE

3 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP

3 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
04/01/2026	Granules India Limited	India	Pharmapia Co., Ltd.	Su258-50-ND	Pazopanib Hydrochloride	2025-11-24	Granules India Limited (Unit-Ⅴ)	India	Plot No. 30, Jawaharlal Nehru Pharma City, Parawada (M), Anakapalli District-531 019, Andhra Pradesh State, India.
30/12/2025	F.I.S. Fabbrica Italiana Sintetici	Italy	Novartis Korea Co., Ltd.	Su196-26-ND	Pazopanib hydrochloride	2023-07-12	FIS Fabbrica Italiana Sintetici SpA@Catalent Micron Technologies Limited	Italy	Viale Milano, 26, 36075 Montecchio Maggiore (Vicenza), Italy@Crossways Boulevard, Crossways, Dartford, Kent DA2 6QY, UK

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

GW786034, VOTRIENT,Pazopanib Hydrochloride|

GW786034, VOTRIENT,Pazopanib Hydrochloride|

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers

14 USDMF

1 JDMF

8 EU WC

6 KDMF

9 NDC API

34 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

96 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

96 FDF Dossiers

8 FDA Orange Book

36 Europe

3 Canada

24 Australia

7 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

5 DKSH

1 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 ACG Worldwide

2 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

10 BASF

1 Clariant

10 Corel Pharma Chem

3 DFE Pharma

9 Gangwal Chemicals

4 Ideal Cures

1 Ingredion Pharma Solutions

10 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

9 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

3 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

11 Roquette

12 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives

30 Fillers, Diluents & Binders

17 Controlled & Modified Release

17 Solubilizers

16 Thickeners and Stabilizers

15 Disintegrants & Superdisintegrants

13 Granulation

13 Direct Compression

10 Lubricants & Glidants

10 Film Formers & Plasticizers

9 Parenteral

TABLET;ORAL - EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons